Showing results (51-60 of 135) with videos related to
Sort By:
Pageof 14
Biochemical and Biophysical Research Communications|October 15, 1992
P-glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding siteD R Ferry, M A Russell, M H CullenJournal of Psychopharmacology (Oxford, England)|January 1, 1997
Effect of haloperidol on nicotine-induced enhancement of vigilance in human subjectsC Lee, S Frangou, M A Russell, et al.Psychopharmacology|August 1, 1995
Naltrexone, smoking behaviour and cigarette withdrawalG Sutherland, J A Stapleton, M A Russell, et al.Thorax|April 1, 1993
Glycerol particle cigarettes: a less harmful option for chronic smokersG Sutherland, M A Russell, J A Stapleton, et al.Psychopharmacology|January 1, 1995
Nicotine intake in smokers increases following a single dose of haloperidolS Dawe, C Gerada, M A Russell, et al.Psychopharmacology|January 1, 1992
Nicotine intake and dependence in Swedish snuff takersH Holm, M J Jarvis, M A Russell, et al.JAMA|June 19, 1987
Nicotine replacement in smoking cessation. Absorption of nicotine vapor from smoke-free cigarettesM A Russell, M J Jarvis, G Sutherland, et al.British Medical Journal (Clinical Research Ed.)|August 21, 1982
Randomised controlled trial of nicotine chewing-gumM J Jarvis, M Raw, M A Russell, et al.British Medical Journal|August 16, 1980
Comparison of nicotine chewing-gum and psychological treatments for dependent smokersM Raw, M J Jarvis, C Feyerabend, et al.British Medical Journal (Clinical Research Ed.)|February 26, 1983
Nasal nicotine solution: a potential aid to giving up smoking?M A Russell, M J Jarvis, C Feyerabend, et al.Pageof 14